ProteoGenix is an antibody production company founded in 2003. They partner with pharmaceutical and biotechnology companies for their custom assay development and therapeutic antibody discovery:
- Antibody generation including antigen design: hybridoma technology, phage display or single B cell
- Antibody engineering: humanization, affinity maturation, reformatting (bispecific antibodies, ADC, etc.), subtype or isotype switching
- Antibody production: recombinant monoclonal antibody production, stable cell line development
- Protein production: E. coli, B. subtilis, yeast, insect cells, mammalian cells
- Custom peptide synthesis
- Custom gene synthesis